Outlook Therapeutics Inc. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Red day on Wednesday for Outlook Therapeutics Inc. stock after losing 0%
(Updated on Apr 24, 2024)
No changes to the price of Outlook Therapeutics Inc. stock on the last trading day (Wednesday, 24th Apr 2024). During the last trading day the stock fluctuated 7.88% from a day low at $8.00 to a day high of $8.63. The price has fallen in 6 of the last 10 days and is down by -8.79% for this period.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 374.89% during the next 3 months and, with a 90% probability hold a price between $28.70 and $73.56 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
OTLK Signals & Forecast
The Outlook Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $8.33. On a fall, the stock will find some support from the long-term average at approximately $7.21. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. The volume rose on the last day while price remained unchanged. This may be an early warning and the stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -31.32%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Outlook Therapeutics Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $7.79 and $7.04. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Outlook Therapeutics Inc. finds support just below today's level at $7.79. If this is broken, then the next support from accumulated volume will be at $7.04 and $6.78.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.630 between high and low, or 7.88%. For the last week, the stock has had daily average volatility of 7.07%.
Outlook Therapeutics Inc. is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: $7.72 (-5.89%) (This stock has high daily movements and this gives high risk. Low RSI14 is 18 which reduces the risk some. There is a sell signal from a pivot top found 18 days ago.)
Trading Expectations (OTLK) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect Outlook Therapeutics Inc. to open at $8.28, and during the day (based on 14 day Average True Range), to move between $7.32 and $9.08, which gives a possible trading interval of +/-$0.88 (+/-10.79%) up or down from last closing price. If Outlook Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 21.57% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $8.24 (0.49%) than the support at $7.79 (5.06%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Outlook Therapeutics Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Outlook Therapeutics Inc. stock to perform well in the short-term.
Current score: 1.873 Buy Candidate Unchanged
Predicted Opening Price for Outlook Therapeutics Inc. of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $8.28 ( 0.93%) | $8.20 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for OTLK
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 8.91 | 8.62 % | |
| R2 | 8.67 | 5.68 % | ||
| R1 | 8.52 | 3.87 % | ||
| Current price: | 8.20 | |||
| Support | S1 | 8.04 | -2.00 % | |
| S2 | 7.89 | -3.81 % | ||
| S3 | 7.65 | -6.75 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 9.37 | 14.27 % | |
| R2 | 8.63 | 5.24 % | ||
| R1 | 8.24 | 0.488 % | ||
| Current price | 8.20 | |||
| Support | S1 | 7.79 | -5.06% | |
| S2 | 7.04 | -14.15% | ||
| S3 | 6.78 | -17.32% |
FAQ
Click here for our free guide on how to buy Outlook Therapeutics Inc. Stock.
